Approval · Notice of Compliance 30982 · 2023
ONPATTRO: Notice of Compliance 30982
Issued June 13, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30982
- Date
- June 13, 2023
- Company
- Alnylam Netherlands B.V.Amsterdam, --, Netherlands
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph (PM) and migration of the PM to the 2020 Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONPATTRO | Not yet assigned | — |
Medicinal ingredients
- PATISIRAN SODIUM 2 MG per ML